Emerging Diseases News

HHS Secretary Robert F. Kennedy Jr. is moving to terminate COVID-19 emergency use authorization declarations for drugs, biologics and medical devices, the agency announced.

The CDC has officially ended its response to the deadly hantavirus outbreak that triggered federal quarantines of American citizens and several weeks of health monitoring.

NASHVILLE, Tenn. — If a suspected Ebola case should enter your medical facility, above all else, stay calm.

The 2024-2025 COVID-19 vaccine was associated with reduced risk for COVID-19-related major adverse cardiovascular events among older adults, especially those with comorbidities, researchers reported.

Gregory C. Gray, MD, MPH, FIDSA, wants to get the word out: The time is now to vaccinate U.S. dairy cattle against bird flu.

Infectious disease experts say measles — not Ebola or hantavirus — is the biggest infectious threat to the mega-events that will be held in the Unites States this summer.

ACOG released its 2026 maternal immunization schedule, which for the first time differs from recommendations by federal health agencies, according to the organization.

A study that compared the efficacy of moxifloxacin vs. azithromycin in treating Mycoplasma genitalium — an STI with a rising resistance to antibiotics — showed that moxifloxacin was the clear winner.

Secretary of State Marco Rubio said last week that the United States would “reengage” with Gavi, the Vaccine Alliance, nearly a year after HHS Secretary Robert F. Kennedy Jr. pulled funding for the global vaccine distributor.